INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/08/2024
Back to search
Official data from USPTO
GOLDILOX-T
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/08/2024
Trademark type
Combined
Nice classes
5
Filing date
06/21/2016
Registration date
05/23/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2023
Last transaction
12/08/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
AU
Examiner
KIDWELL WALKER, JACLYN
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of wording "GOLDI" appearing in a polygon followed by the wording "LOX-T" with a stylized head of a bear above this wording.
Holders and representatives
Holders
Cartherics Pty Ltd
Representatives
Joseph G. Chu JCIP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical purposes for the treatment of cancer; biological preparations for pharmaceutical purposes for the treatment of cancer; biological preparations for medical use in biotechnology for the treatment of cancer; biological products for medical useCytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; biological substances for medical useCytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; therapeutic biological products for medical useCytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen
Publications
History of USPTO decisions and trademark events.
34 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/20/2024
INPC
INVALIDATION PROCESSED
08/20/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/09/2024
C71T
CANCELLED SECTION 71
12/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/19/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/23/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/24/2017
FIMP
FINAL DISPOSITION PROCESSED
08/24/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/23/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2017
PUBO
PUBLISHED FOR OPPOSITION
03/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/30/2016
RFNT
REFUSAL PROCESSED BY IB
11/18/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/01/2016
RFRR
REFUSAL PROCESSED BY MPU
11/01/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/31/2016
CNRT
NON-FINAL ACTION WRITTEN
10/30/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2016
DOCK
ASSIGNED TO EXAMINER
10/18/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2016
Continuous trademark protection
Get notified about every new filing that threatens GOLDILOX-T or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.